Amneal to Participate at Upcoming Investor Conferences in June
Amneal Pharmaceuticals (NASDAQ: AMRX) has announced its participation in two major investor conferences in June 2025. The company will present at the Jefferies Global Healthcare Conference on June 5 at 9:20 AM ET and participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 10 at 10:40 AM ET.
Co-CEO and President Chirag Patel and CFO Tasos Konidaris will represent Amneal at both events. Investors can access live webcasts through the company's investor relations website, with replay options available after the events.
Amneal Pharmaceuticals (NASDAQ: AMRX) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. L'azienda presenterà al Jefferies Global Healthcare Conference il 5 giugno alle 9:20 ET e parteciperà a una discussione informale al Goldman Sachs Global Healthcare Conference il 10 giugno alle 10:40 ET.
Il Co-CEO e Presidente Chirag Patel e il CFO Tasos Konidaris rappresenteranno Amneal in entrambi gli eventi. Gli investitori potranno seguire le dirette streaming tramite il sito web delle relazioni con gli investitori dell'azienda, con la possibilità di rivedere le registrazioni dopo gli eventi.
Amneal Pharmaceuticals (NASDAQ: AMRX) ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La compañía presentará en la Jefferies Global Healthcare Conference el 5 de junio a las 9:20 AM ET y participará en una charla informal en la Goldman Sachs Global Healthcare Conference el 10 de junio a las 10:40 AM ET.
El Co-CEO y Presidente Chirag Patel y el CFO Tasos Konidaris representarán a Amneal en ambos eventos. Los inversores podrán acceder a las transmisiones en vivo a través del sitio web de relaciones con inversores de la compañía, con opciones de repetición disponibles después de los eventos.
Amneal Pharmaceuticals (NASDAQ: AMRX)는 2025년 6월에 열리는 두 개의 주요 투자자 컨퍼런스에 참여할 것이라고 발표했습니다. 회사는 6월 5일 오전 9시 20분(동부시간)에 Jefferies Global Healthcare Conference에서 발표를 진행하며, 6월 10일 오전 10시 40분(동부시간)에는 Goldman Sachs Global Healthcare Conference에서 대담에 참여합니다.
Co-CEO 겸 사장인 Chirag Patel와 CFO Tasos Konidaris가 두 행사에 모두 참석하여 Amneal을 대표할 예정입니다. 투자자들은 회사의 투자자 관계 웹사이트를 통해 생중계에 접속할 수 있으며, 행사 후 다시보기 서비스도 제공됩니다.
Amneal Pharmaceuticals (NASDAQ: AMRX) a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025. La société présentera lors de la Jefferies Global Healthcare Conference le 5 juin à 9h20 ET et participera à une discussion informelle lors de la Goldman Sachs Global Healthcare Conference le 10 juin à 10h40 ET.
Le Co-CEO et Président Chirag Patel ainsi que le CFO Tasos Konidaris représenteront Amneal lors des deux événements. Les investisseurs pourront accéder aux webdiffusions en direct via le site des relations investisseurs de la société, avec des options de replay disponibles après les événements.
Amneal Pharmaceuticals (NASDAQ: AMRX) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird am Jefferies Global Healthcare Conference am 5. Juni um 9:20 Uhr ET präsentieren und am Goldman Sachs Global Healthcare Conference am 10. Juni um 10:40 Uhr ET an einem Fireside Chat teilnehmen.
Co-CEO und Präsident Chirag Patel sowie CFO Tasos Konidaris werden Amneal bei beiden Veranstaltungen vertreten. Investoren können die Live-Webcasts über die Investor-Relations-Website des Unternehmens verfolgen, mit der Möglichkeit, die Aufzeichnungen nach den Veranstaltungen anzusehen.
- None.
- None.
BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company presentation at 9:20 AM ET, and Goldman Sachs Global Healthcare Conference on June 10, 2025, with fireside chat at 10:40 AM ET. Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Executive Vice President and Chief Financial Officer, will participate in both conferences. A live webcast will be accessible at https://investors.amneal.com with replays available following both events.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.
Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com
FAQ
When is Amneal Pharmaceuticals (AMRX) presenting at the Jefferies Global Healthcare Conference 2025?
What time is AMRX's fireside chat at the Goldman Sachs Global Healthcare Conference 2025?
Who will represent Amneal Pharmaceuticals at the June 2025 investor conferences?
How can investors access Amneal's (AMRX) conference presentations in June 2025?
